"Dr. Darius Schneider and Dr. Daniel Einhorn are physicians and scientists who have devoted our practice exclusively to providing state-of-the-art clinical care for adults with diabetes and endocrine disorders including thyroid, adrenal, pituitary, gonadal disorders, bone, and any diagnostic dilemma that may have a hormonal origin."

During the past decade, Diabetes and Endocrine Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Diabetes and Endocrine Associates" are "Diabetes" (1 trials) and "Diabetes Mellitus, Non-Insulin-Dependent" (1 trials). Many other conditions were trialed in "Diabetes and Endocrine Associates" in a lesser frequency.

Most popular intervention types in "Diabetes and Endocrine Associates" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "INGAP-Peptide" (1 trials), "OneTouch(r) UltraSmart(r)" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabetes and Endocrine Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Diabetes and Endocrine Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Diabetes and Endocrine Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diabetes and Endocrine Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".